Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Solésence To Report Third Quarter 2025 Financial Results and Host a Conference Call
-
New Clinical and Translational Data on PDS Biotechnology’s Novel Investigational Cancer Therapies PDS0101 and PDS01ADC to be Presented at the 2025 Society for Immunotherapy of Cancer (SITC) Annual
-
Sun Auto Tire & Service Welcomes Susie Long as Chief People Officer
-
Arcutis Launches ZORYVE® (roflumilast) Cream 0.05% for the Treatment of Mild to Moderate Atopic Dermatitis in Children Ages 2 to 5
-
Charles River Associates (CRA) Increases Quarterly Cash Dividend 16% to $0.57 Per Common Share
-
Ultragenyx Announces First Patient Dosed in Aurora Study Evaluating GTX-102 in Additional Angelman Syndrome Genotypes and Age Groups
-
Rick Sherlund, Wall Street Legend, joins in Partnership with Wedbush Tech Investment Banking
-
Celularity and DefEYE, Inc. Partner to Advance Growth of Regenerative Therapies in Eye Care
-
Biomea Fusion to Present Poster Presentations at ObesityWeek®2025
-
SunPower Executes Major Sales Force Expansion Following Sunder Merger
-
Workhorse Reminds Shareholders to Vote Today FOR All Proposals
-
Monster Beverage to Report Financial Results for 2025 Third Quarter on November 6, 2025
-
Incannex Provides Shareholder Update Highlighting Clinical Progress, Capital Discipline, and EOY 2025 Strategic Focus
-
ZenaTech to Highlight Drone as a Service, AI Drone Solutions, and US Defense Initiatives at Three Upcoming Investor Conferences
-
Rumble Announces Timing of Third Quarter 2025 Earnings Release and Conference Call
-
Calidi Biotherapeutics Announces New Data to be Presented on its Therapeutic Lead, CLD-401, at the 2025 SITC Annual Meeting
-
Kinetic Teams Up With eero to Deliver Next-Gen Secure Home Wi-Fi
-
Harvard Bioscience Schedules Third Quarter 2025 Earnings Conference Call for November 6, 2025 at 8:00 AM ET
-
Incyte to Present at Upcoming Investor Conferences
-
Solid Biosciences to Participate at Upcoming Investor Conferences
-
Lisata Therapeutics to Report Third Quarter 2025 Financial Results and Provide a Business Update on Thursday, November 6, 2025
-
23andMe Research Institute Appoints Privacy Advisory Board
-
Barry Hytinen Appointed to ABM’s Board of Directors
-
Edible Garden Receives Preliminary Approval to Sell Up to $3.35 Million in Tax Credits Through NJEDA Program
-
UroGen Pharma to Report Third Quarter 2025 Financial Results on Thursday, November 6th, 2025
-
Pacira to Report Third Quarter 2025 Financial Results on Thursday November 6, 2025
-
RedChip Companies Announces Sponsorship of the 2025 ThinkEquity Conference
-
ARIA Cybersecurity Adds Features To Expand AZT PROTECT(TM) Into the Embedded IIOT Market
-
T-knife Therapeutics Announces Four Upcoming Data Presentations on PRAME-Targeted TK-6302 at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
-
Troy Minerals Updates on the Operational Mining Permit for its Tsagaan Zalaa Silica Project, Mongolia and Initiates Commodity Off-Take Discussions
-
Kojamo plc’s Interim Report 1 January–30 September 2025
-
United States Antimony Corporation Updates Significant Montana Antimony Mining Activities
-
Rani Therapeutics to Present Preclinical Data on Oral Delivery of Semaglutide via the RaniPill® Capsule at ObesityWeek® 2025
-
EnviroShred Wins 2025 Consumer Choice Award for Excellence in Shredding Services in Southern Alberta
-
Twin Vee PowerCats Co. to Host Q3 2025 Earnings Call on November 6
-
Harvia will publish its Interim report for January–September 2025 on Thursday, 6 November 2025 at around 9:00 a.m. EET
-
Golden Grail Beverages Announces Stock Dividend has Been Distributed to Shareholders
-
Municipality Finance will redeem early notes issued under its MTN programme
-
Evaxion raises $7.2 million, extending cash runway to second half of 2027
-
OrganOx Completes Acquisition by Terumo Corporation to Advance the Future of Organ Transplantation
-
Ramsey Theory Group CEO Dan Herbatschek Urges Enterprises to Prepare for Post-SaaS Era as AI Agents Reshape Software Delivery and Licensing Models
-
Clearmind Medicine Completes First Cohort Treatment in its FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder
-
Cleveland-Cliffs Announces POSCO as MoU Counterparty as Korea Trade Agreement Takes Effect
-
XPENG to Host 2025 XPENG AI Day
-
World Copper Announces Closing of Sale of Zonia Copper Project
-
Polaris Renewable Energy Announces Q3 2025 Results
-
Polaris Renewable Energy Declares Quarterly Dividend
-
Higher education enrolments in Dubai to increase 40% by 2030, new study by Dubai's leading education hubs finds
-
Equifax Introduces Unemployment Claims Power of Attorney Manager
-
Marcus Corporation Announces Mark A. Gramz to Retire

